By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – CombiMatrix today reported that its fourth-quarter revenues rose 52 percent year over year.

For the three months ended Dec. 31, 2011, revenues totaled $1.2 million, compared to $804,000 a year ago as diagnostic services revenues, which comprised all of CombiMatrix's revenues in Q4 2011, increased 55 percent from $791,000 a year ago.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers find that a personalized medicine approach could help people who experience pain while taking statins, New Scientist reports.

US National Science Foundation is continuing its responsible research conduct training policy despite its flaws, ScienceInsider reports.

A CRISPR-themed meeting explored how the tool could and should be used, Wired reports.

In Science this week: database of proteins' effects on cancer, targeted error correction sequencing, and more.